ANCR.L
Animalcare Group plc [ANCR.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ANCR.L Stock Summary
Top 10 Correlated ETFs
ANCR.L
Top 10 Correlated Stocks
ANCR.L
In the News
ANCR.L Financial details
Company Rating
Buy
Market Cap
129.29M
Income
3.17M
Revenue
143.23M
Book val./share
1.32
Cash/share
0.11
Dividend
0.04
Dividend %
2.59%
Employees
220
Optionable
No
Shortable
Yes
Earnings
09 Apr 2024
P/E
51.95
Forward P/E
-
PEG
-0.13
P/S
1.42
P/B
1.29
P/C
1981.82
P/FCF
15.73
Quick Ratio
0.88
Current Ratio
1.52
Debt / Equity
0.14
LT Debt / Equity
0.13
-
-
EPS (TTM)
0.05
EPS next Y
-
EPS next Q
-
EPS this Y
-2638.46%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-0.24%
Revenue Q/Q
10.15%
EPS Q/Q
-456.76%
-
-
-
-
SMA20
0.94%
SMA50
18.13%
SMA100
22.16%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
2%
ROC
0.03%
Gross Margin
57%
Oper. Margin
5%
Profit Margin
3%
Payout
135%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
160.0-230.0
52W High
-5.22%
52W Low
+36.25%
RSI
64
Rel Volume
1.73
Avg Volume
32.88K
Volume
56.92K
Perf Week
3.81%
Perf Month
-1.8%
Perf Quarter
26.38%
Perf Half Y
21.11%
-
-
-
-
Beta
0.54
-
-
Volatility
1.81%, 5.57%
Prev Close
0.46%
Price
218
Change
1.02%
ANCR.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.21 | 1.18 | 1.17 | 1.22 | 1.18 | |
| Net income per share | 0 | -0.02 | 0 | 0 | 0.03 | |
| Operating cash flow per share | 0.12 | 0.22 | 0.18 | 0.23 | 0.16 | |
| Free cash flow per share | 0.04 | 0.18 | 0.14 | 0.18 | 0.11 | |
| Cash per share | 0.13 | 0.1 | 0.09 | 0.09 | 0.1 | |
| Book value per share | 1.44 | 1.36 | 1.36 | 1.3 | 1.3 | |
| Tangible book value per share | -1.12 | -0.19 | -0.12 | -0.02 | 0.05 | |
| Share holders equity per share | 1.44 | 1.36 | 1.36 | 1.3 | 1.3 | |
| Interest debt per share | 0.54 | 0.41 | 0.32 | 0.19 | 0.2 | |
| Market cap | 90.02M | 105.1M | 120.2M | 208.58M | 138.33M | |
| Enterprise value | 113.61M | 122.91M | 133.82M | 213.91M | 143.73M | |
| P/E ratio | -405.5 | -78.55 | 513.67 | -2.71K | 70.4 | |
| Price to sales ratio | 1.24 | 1.48 | 1.71 | 2.82 | 1.93 | |
| POCF ratio | 12.12 | 8.02 | 10.81 | 14.87 | 14.67 | |
| PFCF ratio | 33.98 | 9.81 | 13.84 | 19.3 | 21.34 | |
| P/B Ratio | 1.04 | 1.28 | 1.47 | 2.65 | 1.75 | |
| PTB ratio | 1.04 | 1.28 | 1.47 | 2.65 | 1.75 | |
| EV to sales | 1.57 | 1.73 | 1.9 | 2.89 | 2.01 | |
| Enterprise value over EBITDA | 10.75 | 10.51 | 11.17 | 20.99 | 11.9 | |
| EV to operating cash flow | 15.29 | 9.38 | 12.04 | 15.25 | 15.24 | |
| EV to free cash flow | 42.89 | 11.47 | 15.41 | 19.79 | 22.17 | |
| Earnings yield | 0 | -0.01 | 0 | 0 | 0.01 | |
| Free cash flow yield | 0.03 | 0.1 | 0.07 | 0.05 | 0.05 | |
| Debt to equity | 0.37 | 0.29 | 0.23 | 0.14 | 0.14 | |
| Debt to assets | 0.22 | 0.19 | 0.15 | 0.1 | 0.1 | |
| Net debt to EBITDA | 2.23 | 1.52 | 1.14 | 0.52 | 0.45 | |
| Current ratio | 1.96 | 1.72 | 1.54 | 1.68 | 1.52 | |
| Interest coverage | 3.57 | 3.56 | 5.02 | 4.45 | 7.29 | |
| Income quality | -6.56 | -8.15 | 55.86 | 14.84 | 3.71 | |
| Dividend Yield | 0.03 | 0.03 | 0.01 | 0.01 | 0.02 | |
| Payout ratio | -10.82 | -1.97 | 5.13 | -31.21 | 1.35 | |
| Sales general and administrative to revenue | 0.16 | 0.18 | 0.19 | 0.2 | 0.21 | |
| Research and developement to revenue | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | |
| Intangibles to total assets | 1.07 | 0.73 | 0.71 | 0.73 | 0.64 | |
| Capex to operating cash flow | -0.64 | -0.18 | -0.22 | -0.23 | -0.31 | |
| Capex to revenue | -0.07 | -0.03 | -0.03 | -0.04 | -0.04 | |
| Capex to depreciation | -0.58 | -0.25 | -0.26 | -0.38 | -0.38 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.01 | |
| Graham number | 0.35 | 0.83 | 0.34 | 0.19 | 0.97 | |
| ROIC | 0.01 | 0.02 | 0.03 | 0 | 0.03 | |
| Return on tangible assets | 0.02 | -0.04 | 0.01 | 0 | 0.05 | |
| Graham Net | -0.53 | -0.44 | -0.39 | -0.25 | -0.27 | |
| Working capital | 18.99M | 12.98M | 10.42M | 9.84M | 11.52M | |
| Tangible asset value | -67.01M | -11.57M | -7.21M | -1.26M | 2.85M | |
| Net current asset value | -18.21M | -15.45M | -13.05M | -6.91M | -5.46M | |
| Invested capital | 0.37 | 0.29 | 0.23 | 0.14 | 0.14 | |
| Average receivables | 15.44M | 11.99M | 10.52M | 8.64M | 10.35M | |
| Average payables | 13.02M | 11.12M | 10.84M | 10.68M | 12.76M | |
| Average inventory | 15.84M | 13M | 11.95M | 11.56M | 11.9M | |
| Days sales outstanding | 65.9 | 55.89 | 52.51 | 35.18 | 69.15 | |
| Days payables outstanding | 123.71 | 110.44 | 122.06 | 105.69 | 182.72 | |
| Days of inventory on hand | 154.71 | 118.65 | 137.64 | 108.93 | 158.87 | |
| Receivables turnover | 5.54 | 6.53 | 6.95 | 10.37 | 5.28 | |
| Payables turnover | 2.95 | 3.3 | 2.99 | 3.45 | 2 | |
| Inventory turnover | 2.36 | 3.08 | 2.65 | 3.35 | 2.3 | |
| ROE | 0 | -0.02 | 0 | 0 | 0.02 | |
| Capex per share | -0.08 | -0.04 | -0.04 | -0.05 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.65 | 0.58 | 0.63 | 0.55 | 0.6 | |
| Net income per share | 0.01 | -0.01 | 0.04 | -0.01 | 0.03 | |
| Operating cash flow per share | 0.1 | 0.13 | 0.02 | 0.13 | 0.05 | |
| Free cash flow per share | 0.07 | 0.1 | -0.01 | 0.11 | 0.03 | |
| Cash per share | 0.08 | 0.09 | 0.08 | 0.1 | 0.11 | |
| Book value per share | 1.35 | 1.31 | 1.32 | 1.31 | 1.32 | |
| Tangible book value per share | -0.04 | -0.02 | 0.03 | 0.05 | 0.13 | |
| Share holders equity per share | 1.35 | 1.31 | 1.32 | 1.31 | 1.32 | |
| Interest debt per share | 0.27 | 0.21 | 0.24 | 0.21 | 0.2 | |
| Market cap | 202.76M | 207.32M | 163.41M | 136.71M | 110.37M | |
| Enterprise value | 213.64M | 212.65M | 171.9M | 142.11M | 114.98M | |
| P/E ratio | 154.54 | -127.97 | 16.97 | -77.32 | 17.18 | |
| Price to sales ratio | 5.18 | 5.94 | 4.27 | 4.1 | 3.01 | |
| POCF ratio | 34.33 | 27.03 | 133.83 | 17.61 | 34.65 | |
| PFCF ratio | 49.76 | 32.98 | -452.66 | 21.36 | 59.02 | |
| P/B Ratio | 2.48 | 2.63 | 2.04 | 1.73 | 1.37 | |
| PTB ratio | 2.48 | 2.63 | 2.04 | 1.73 | 1.37 | |
| EV to sales | 5.46 | 6.09 | 4.49 | 4.26 | 3.13 | |
| Enterprise value over EBITDA | 25.32 | 43.31 | 21.6 | 28.92 | 16.09 | |
| EV to operating cash flow | 36.17 | 27.72 | 140.78 | 18.3 | 36.1 | |
| EV to free cash flow | 52.43 | 33.83 | -476.17 | 22.21 | 61.49 | |
| Earnings yield | 0 | 0 | 0.01 | 0 | 0.01 | |
| Free cash flow yield | 0.02 | 0.03 | 0 | 0.05 | 0.02 | |
| Debt to equity | 0.19 | 0.14 | 0.17 | 0.14 | 0.14 | |
| Debt to assets | 0.13 | 0.1 | 0.12 | 0.1 | 0.1 | |
| Net debt to EBITDA | 1.29 | 1.09 | 1.07 | 1.1 | 0.65 | |
| Current ratio | 1.7 | 1.68 | 1.59 | 1.52 | 1.76 | |
| Interest coverage | 3.64 | 0.56 | 5.91 | 0.89 | 4.78 | |
| Income quality | 18.01 | -18.94 | 0.51 | -17.57 | 1.98 | |
| Dividend Yield | 0 | 0.01 | 0 | 0.02 | 0 | |
| Payout ratio | 0 | -5.93 | 0 | -5.98 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.7 | 0.73 | 0.67 | 0.64 | 0.64 | |
| Capex to operating cash flow | -0.31 | -0.18 | -1.3 | -0.18 | -0.41 | |
| Capex to revenue | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 | |
| Capex to depreciation | -0.42 | -0.34 | -0.41 | -0.34 | -0.35 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.41 | 0.45 | 1.09 | 0.47 | 0.89 | |
| ROIC | 0.02 | -0.02 | 0.03 | 0 | 0.02 | |
| Return on tangible assets | 0.01 | -0.01 | 0.06 | -0.01 | 0.04 | |
| Graham Net | -0.33 | -0.25 | -0.24 | -0.27 | -0.17 | |
| Working capital | 12.24M | 9.84M | 12.06M | 11.52M | 14.47M | |
| Tangible asset value | -2.31M | -1.26M | 1.84M | 2.85M | 7.61M | |
| Net current asset value | -8.3M | -6.91M | -3.93M | -5.46M | 257K | |
| Invested capital | 0.19 | 0.14 | 0.17 | 0.14 | 0.14 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 23.54 | 18.4 | 32.47 | 36.64 | 33.97 | |
| Days payables outstanding | 39.04 | 43.11 | 49.28 | 77.16 | 57.03 | |
| Days of inventory on hand | 48.71 | 44.43 | 52.53 | 67.09 | 53.84 | |
| Receivables turnover | 3.82 | 4.89 | 2.77 | 2.46 | 2.65 | |
| Payables turnover | 2.31 | 2.09 | 1.83 | 1.17 | 1.58 | |
| Inventory turnover | 1.85 | 2.03 | 1.71 | 1.34 | 1.67 | |
| ROE | 0 | -0.01 | 0.03 | -0.01 | 0.02 | |
| Capex per share | -0.03 | -0.02 | -0.03 | -0.02 | -0.02 |
ANCR.L Frequently Asked Questions
What is Animalcare Group plc stock symbol ?
Animalcare Group plc is a GB stock and trading under the symbol ANCR.L
What is Animalcare Group plc stock quote today ?
Animalcare Group plc stock price is $218 today.
Is Animalcare Group plc stock public?
Yes, Animalcare Group plc is a publicly traded company.
Company Profile
- Volume Average 32.88K
- Market Capitalization 129.29M
- Employee 220
- CEO Ms. Jennifer Ann Julia Winter B.Sc.
- Headquarters York,GB
- IPO Date 2008-01-15
-
Website
https://www.animalcaregroup.com 
Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets. It is also involved in the wholesale and marketing of veterinary pharmaceuticals. The company serves customers in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, Africa, and internationally. Animalcare Group plc was incorporated in 1972 and is based in York, the United Kingdom.
